A Study of Insulin Glargine (LY2963016) in Adult Participants With Type 2 Diabetes in India
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 304 participants.
Also called NCT04153981
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 304 participants
- Sponsor
- Registry
-
NCT04153981
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- India
- Registry status
- Completed
Technical summary
Registry record NCT04153981. Allocation not applicable; no masking; primary purpose treatment. Start 2019-12-16 (actual); primary completion 2021-07-30 (actual). Results posted on 2024-02-15.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of Insulin Glargine (LY2963016) in Adult Participants With Type 2 Diabetes in India
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- Insulin Glargine
- Lead sponsor
- Eli Lilly and Company
Record details
- Record id
cardio:ct-nct04153981- Content hash
1b4da8e271929b20e769fc580f2250adb4507916120f8f16a2d900828caf363f